Resumo

GUZMAN-MENDOZA, M  e  FLORES-A, M. Acquired pure aplasia of red cells and chronic kidney disease in renal replacement therapy type hemodialysis. Cuad. - Hosp. Clín. [online]. 2019, vol.60, n.Especial, pp.56-60. ISSN 1562-6776.

Abstract Acquired pure red cells aplasia (PRCA) is a rare hematopoietic disorder characterized by normocytic and normochromic anemia, reticulocytopenia and absence of erythroid precursors in bone marrow, frequency that has been increasing in patients with chronic kidney disease. We present the case of a 38-year-old man with systemic hypertension in hemodialysis therapy. During the course of the disease, acute anemia was observed. After a study protocol, pure erythroid cell aplasia was detected by anti-erythropoietin antibodies, the patient received boluses of cyclophosphamide, chemoprophylaxis, dialysis therapy, erythropoietin was suspended, with favorable evolution. Subsequently, the kidney transplant.

Palavras-chave : Pure aplasia of red cells; chronic kidney disease; hemodialysis; erythropoietin; anemia.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )